In general, efficient IN delivery to the CNS in humans can be achieved by optimizing the right combination of formulation delivery device, delivery volume, and head position to target specific nasal cavity regions [8]
Njlsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S
Some evidence suggests semaglutide may have slightly higher discontinuation rates due to GI symptoms compared to some other GLP-1 agonists, though this varies by dose and individual factors
Good Laboratory Practices (GLP): Adhering to GLP principles ensures the quality and integrity of non-clinical laboratory studies
345,346 GLP-1 may also reduce the expression of cartilage-degrading enzymes by inhibiting the MAPK pathway or activating anti-inflammatory pathways such as PI3K/Akt, thereby alleviating cartilage damage